Endoscopic submucosal dissection<i>vs</i>endoscopic mucosal resection for early gastric cancer: A meta-analysis

Facciorusso, Antonio; Antonino, Matteo; Maso, M. Di; Muscatiello, Nicola

doi:10.4253/wjge.v6.i11.555

Cited by 157 publications

(96 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[2][3][4] In our review, bleeding after ESD occurred in 5.1% of all procedures. We believe this is the best estimate for PPB because all studies included were selected only if a clear definition of PPB was provided and reported separately from intraprocedural bleeding.…”

Section: Discussionmentioning

confidence: 99%

Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis

Libânio

Costa

Pimentel‐Nunes

et al. 2016

Gastrointestinal Endoscopy

112

127

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis

Libânio

Costa

Pimentel‐Nunes

et al. 2016

Gastrointestinal Endoscopy

112

127

View full text Add to dashboard Cite

show abstract

“…ESD showed a superior efficacy with respect to endoscopic mucosal resection in a recent meta-analysis[3]. As adoption of this procedure becomes ever more widespread, the indications for endoscopic therapy are being expanded[4].…”

Section: Introductionmentioning

confidence: 99%

Clinical importance of colonoscopy in patients with gastric neoplasm undergoing endoscopic submucosal dissection

Tsuchida

Yoshitake

Kino

et al. 2017

WJG

View full text Add to dashboard Cite

AIMTo evaluate the usefulness of total colonoscopy (TCS) for patients undergoing gastric endoscopic submucosal dissection (ESD) and to assess risk factors for colorectal neoplasms.METHODSOf the 263 patients who underwent ESD at our department between May 2010 and December 2013, 172 patients undergoing TCS during a one-year period before and after ESD were targeted. After excluding patients with a history of surgery or endoscopic therapy for colorectal neoplasms, 158 patients were analyzed. Of the 868 asymptomatic patients who underwent TCS during the same period because of positive fecal immunochemical test (FIT) results, 158 patients with no history of either surgery or endoscopic therapy for colorectal neoplasms who were matched for age and sex served as the control group for comparison.RESULTSTCS revealed adenoma less than 10 mm in 53 patients (33.6%), advanced adenoma in 17 (10.8%), early colorectal cancer in 5 (3.2%), and advanced colorectal cancer in 4 (2.5%). When the presence or absence of adenoma less than 10 mm, advanced adenoma, and colorectal cancer and the number of adenomas were compared between patients undergoing ESD and FIT-positive patients, there were no statistically significant differences in any of the parameters assessed. The patients undergoing ESD appeared to have the same risk of colorectal neoplasms as the FIT-positive patients. Colorectal neoplasms were clearly more common in men than in women (P = 0.031). Advanced adenoma and cancer were significantly more frequent in patients with at least two of the following conditions: hypertension, dyslipidemia, and diabetes mellitus (P = 0.019).CONCLUSIONIn patients undergoing gastric ESD, TCS appears to be important for detecting synchronous double neoplasms. Advanced adenoma and cancer were more common in patients with at least two of the following conditions: hypertension, dyslipidemia, and diabetes mellitus. Caution is therefore especially warranted in patients with these risk factors.

show abstract

“…Treatment options for gastric cancer include endoscopic treatment, surgery, chemotherapy and radiation (1,3,4). Key types of endoscopic treatment include endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) (5,6). Despite improvements in treatment efficacy, prognoses for gastric cancer remain poor (7).…”

Section: Introductionmentioning

confidence: 99%

Detection of gastric cancer using transabdominal ultrasonography is associated with tumor diameter and depth of invasion

Tomizawa

Shinozaki

Fugo

et al. 2015

Experimental and Therapeutic Medicine

View full text Add to dashboard Cite

Abstract. Gastric cancer is occasionally diagnosed using transabdominal ultrasonography (US) during screening or investigation of patients with abdominal symptoms. Therefore, the present study analyzed the association of the tumor diameter, pathological T (pT) staging and depth of invasion with the detection of gastric cancer using US. Patient records were analyzed retrospectively and 13 patients were enrolled, who underwent US screening prior to endoscopic mucosal resection, endoscopic submucosal dissection or surgery. In total, 5 patients were diagnosed with gastric cancer using US (positive detection group), while US was unable to detect the gastric cancer in 8 patients (negative detection group). The tumor diameter and depth of invasion were determined by pathologists. One-way analysis of variance or the χ 2 test was performed. Wall thickness in gastric cancer cases ranged between 7 and 20 mm (mean, 12.2±5.9 mm), as measured using abdominal US. The hemoglobin level was significantly lower in the positive detection patients compared with the negative detection patients (P=0.0455). In addition, the diameters of the gastric wall in the negative and positive detection patients were 24.5±16.4 and 54.4±26.2 mm, respectively (P=0.0266). These results indicate that gastric cancer in the positive detection patients were at a more advanced-stage compared with that in the negative detection patients. Furthermore, gastric cancer with a stage over pT2 was diagnosed using abdominal US (P=0.0242), whereas stage pT1a gastric cancer was not detected by abdominal US. Gastric tumors invading deeper than the submucosa were diagnosed using US (P=0.0242). However, the gastric cancer cases limited to the mucosa remained undetected. In conclusion, the detection of gastric cancer correlated well with the tumor diameter, pT staging and depth of invasion.

show abstract

Endoscopic submucosal dissectionvsendoscopic mucosal resection for early gastric cancer: A meta-analysis

Abstract: In the endoscopic therapy of EGC, ESD showed a superior efficacy but higher complication rate with respect to EMR.

Cited by 157 publications

References 27 publications

Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis

Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis

Clinical importance of colonoscopy in patients with gastric neoplasm undergoing endoscopic submucosal dissection

Detection of gastric cancer using transabdominal ultrasonography is associated with tumor diameter and depth of invasion

Contact Info

Product

Resources

About